Case Study

R&D
MHRA case study

Case Study: MHRA

Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed. 

Patients
Case Study: MHRA and AstraZeneca
Sponsored

Case Study: MHRA and AstraZeneca

Agile, responsive regulation helps early breast cancer patients to benefit from a study to potentially improve survival outcomes.